checkAd
    Startseite > Aktien > Cytokinetics > Nachrichten
    Cytokinetics Aktie
    45,40
     
    EUR
    -17,45 %
    -9,60 EUR
    Letzter Kurs 17:13:00 Tradegate
    45,60
     
    EUR
    400 STK
    Geldkurs 17:23:55
    45,80
     
    EUR
    400 STK
    Briefkurs 17:23:55
    ISIN: US23282W6057 · WKN: A1W1KK · SYM: KK3A · USA

    Neueste Nachrichten

    Cytokinetics Announces Pricing of Public Offering of Common Stock
    05:30 Uhr · globenewswire · Cytokinetics
    Cytokinetics Announces Proposed Public Offering of Common Stock
    22.05.24 · globenewswire · Cytokinetics
    Cytokinetics and Royalty Pharma Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline
    22.05.24 · globenewswire · Cytokinetics
    Cytokinetics Hosts Muscle Biology-Focused Research Symposium: Contemporary Landscapes in Muscle Biology
    17.05.24 · globenewswire · Cytokinetics
    Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2024
    15.05.24 · globenewswire · Cytokinetics
    Cytokinetics Announces Additional Results From SEQUOIA-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology Heart Failure 2024 Congress
    13.05.24 · globenewswire · Cytokinetics
    Cytokinetics Announces Primary Results From SEQUOIA-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology Heart Failure 2024 Congress and Published in the New England Journal of Medicine
    13.05.24 · globenewswire · Cytokinetics
    Cytokinetics Reports First Quarter 2024 Financial Results
    08.05.24 · globenewswire · Cytokinetics
    Cytokinetics Announces Topline Data From Phase 1 Clinical Study of CK-4021586
    08.05.24 · globenewswire · Cytokinetics
    Cytokinetics Announces Start of CEDAR-HCM, a Clinical Trial of Aficamten in a Pediatric Population With Symptomatic Obstructive Hypertrophic Cardiomyopathy
    08.05.24 · globenewswire · Cytokinetics
    Cytokinetics to Hold Annual Meeting of Stockholders
    07.05.24 · globenewswire · Cytokinetics
    Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    02.05.24 · globenewswire · Cytokinetics